Walaa Ahmad News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tibbiyah buys 51% stake in Saudi medical rival Innovative Care for $57m

RIYADH: Arabian International Healthcare Holding Co. has completed the acquisition of an SR214 million ($57 million) stake in Saudi medical rival Innovative Care Co. Known as Tibbiyah, the company now holds a 51 percent stake in Riyadh-based Innovative Care, which operates New You Medical Center, according to a bourse filing. Established in 2016, New You is a center

Saudi arabiaAr riyaAlaa ahmad ameenAayed alqahtaniInnovative care coArabian international healthcare holding coYou medical centerAl faisaliah groupArabian international healthcare holdingInnovative careRiyadh based innovative careNew you medical centerNew youWalaa ahmadAl ahsaAl kharj

Enanta Pharmaceuticals, Inc : Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress 2022

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta's

United kingdomCity ofWalaa ahmadJennifer vieraManuel roqueta riveraFung yuenEnanta pharmaceuticals incDevelopment programsInternational liver congressEnanta pharmaceuticalsEuropean associationNovel pangenotypic classFinal resultsDay phaseViral hepatitisJordan feld

Enanta Pharmaceuticals Announces Data Presentations at the European Association for the Study of the

WATERTOWN, Mass. (BUSINESS WIRE) Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that data from Enanta’s internal development program portfolio for hepatitis B virus (HBV) and its.

United kingdomCity ofWalaa ahmadManuel roqueta riveraFung yuenEnanta pharmaceuticals incDevelopment programsInternational liver congressEnanta pharmaceuticalsEuropean associationNovel pangenotypic classFinal resultsDay phaseViral hepatitisJordan feldPotent pangenotypic class

A new drug shows promise against respiratory virus, study shows

A new drug shows promise against respiratory virus, study shows
localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.

Walaa ahmadBrenda goodmanJill fosterEnanta pharmaceuticalsWarnermedia companyUniversity of minnesotaCable news network incNew england journalNews network

A new drug shows promise against respiratory virus, study shows

A new antiviral medication against respiratory syncytial virus, or RSV, appears to be safe and lowered viral levels and symptoms significantly more than a placebo, according to the results of

Walaa ahmadJill fosterEnanta pharmaceuticalsWarnermedia companyUniversity of minnesotaCable news network incNew england journalNews networkNational world